Hyperbaric indications and patient selection criteria part 1 of 4

Patient selection criteria for hyperbaric oxygen treatment

Hyperbaric medicine

is an effective pathway in treating a variety of illnesses. While some physicians specialize in hyperbaric medicine, others have limited knowledge. It helps to have a basic background on what hyperbaric oxygen (HBO2) is and what illnesses/indications it is recommended for. In short, when do you send your patient for hyperbaric treatment?

What is hyperbaric oxygen?

First we need to define the terms: Think of oxygen as a drug and the hyperbaric chamber as a dosing device. The mechanisms of action for HBO2 are based on elevation of the partial pressure of inspired oxygen, which is a product of the inspired oxygen (O2) fraction and the hydrostatic pressure. The empirical clinical use of high-pressure oxygen was framed from commonly accepted physiological principles and the laws of Boyle, Dalton and Henry.

The Undersea and Hyperbaric Medical Society defines HBO2 as an intervention in which an individual breathes near-100% oxygen intermittently while inside a hyperbaric chamber that is pressurized to greater than sea-level pressure – i.e., greater than 1 atmosphere absolute/ATA. For clinical purposes the pressure must equal or exceed 1.4 ATA while breathing near-100% oxygen. The United States Pharmacopoeia and Compressed Gas Association Grade A specifies medical-grade oxygen to be not less than 99.0% by volume; the National Fire Protection Association specifies USP medical-grade oxygen.

In certain circumstances hyperbaric oxygen therapy represents the primary treatment while in others it is an adjunct to surgical or pharmacologic interventions. Treatment can be carried out in either a multiplace chamber (Class A) or monoplace (Class B). The Class A chamber holds two or more people – i.e., patients, observers, and/or support personnel; the chamber is pressurized with compressed air while the patients breathe near-100% oxygen via masks, head hoods, or endotracheal tubes. The Class B chamber accommodates a single patient; the entire chamber is pressurized with near-100% oxygen, and the patient breathes the ambient chamber oxygen directly.

This is a whole-body treatment at pressures higher than sea level which is equivalent to 1 atmosphere. According to the UHMS definition and the determination of The Centers for Medicare and Medicaid Services (CMS) and other third-party carriers, breathing medical-grade 100% oxygen at 1 atmosphere of pressure or exposing isolated parts of the body to 100% oxygen does not constitute HBO2 therapy. The patient must receive the oxygen by inhalation within a pressurized chamber at 1.4 ATA or higher, to be clinically effective according to the UHMS.

What illnesses are treatable with hyperbaric oxygen?

Currently the UHMS recognizes 14 indications recommended for HBO2 treatment.

These indications are those for which in vitro and in vivo preclinical research data as well as extensive positive clinical experience and study have become convincing. They include:

  • air or gas embolism
  • arterial insufficiencies
  • central retinal artery occlusion
  • problem wounds
  • carbon monoxide poisoning
  • clostridial myonecrosis, or gas gangrene
  • compromised grafts and flaps
  • acute traumatic ischemias
  • decompression sickness
  • delayed radiation injuries, specifically soft tissue and bony necrosis
  • sudden sensorineural hearing loss
  • intracranial abscess
  • necrotizing soft tissue infections
  • refractory osteomyelitis
  • severe anemia
  • thermal burns

Additional considerations about hyperbaric oxygen

Help with inflammation. Patients treated with HBO2 see clinical improvements from the elevated O2 partial pressures over days and weeks of exposure. It has also been shown to help reduce inflammatory processes, alleviate pain and prevent further injury by lessening leukocyte sequestration, tumor necrosis factor, interleukin-6, intercellular adhesion molecule-1, CD18, tissue myeloperoxidase, lipid peroxidation and other factors that slow healing.

Increase circulation and oxygen. Patients treated with HBO2 breathe roughly twice the amount of oxygen as sea-level air. Over time this wealth of oxygen helps stimulate angiogenesis, the formation of new blood vessels in the tissues. This in turn aids in healing as it delivers much-needed oxygen to damaged tissue. HBO2 enhances the effectiveness of antibiotics and boosts white blood cell count, aiding in recovery.

Preconditioning. Pretreatment with hyperbaric oxygen can result in a state known as preconditioning. This is the induction of physiological and pathophysiological protective changes in the body (e.g., genetic or enzymatic modifications) against predictable, extreme, environment-induced and disease-related damage. Nowadays preconditioning is emerging as a useful adjunct in diving medicine, as well as in the treatment of acute and chronic diseases such as ischemia/reperfusion injury.

Aid after brain injury. Although it is considered investigational, HBO2 after brain injury is being studied. The United States military has sponsored four randomized, double-blind clinical trials of hyperbaric oxygen for persistent post-concussive symptoms after mild traumatic brain injury.

Here’s a breakdown of results thus far.

  • One of these trials found no within-group changes in post-concussive symptoms, but post-traumatic stress symptoms improved with hyperbaric oxygen at 2.0 atmospheres absolute.
  • Two of these trials reported symptom improvement in both the hyperbaric oxygen sham groups.
  • The fourth trial found improvement in post-concussive symptoms with hyperbaric oxygen but not sham, more dramatically in those with post-traumatic stress disorder, but improvement at six months in eye tracking in both groups. Symptom improvements were not significant at 12 months.

Another study (an open-label, crossover design) from the University of Tel Aviv reported improved symptoms, cognitive function, and brain SPECT scans in civilians with mild traumatic brain injury after hyperbaric oxygen. Further research is needed regarding optimal pressure and frequency of hyperbaric oxygen and patient selection to ultimately lead to a phase III efficacy trial.

There’s more.

For a brief look at how hyperbaric oxygen works on each of the 14 indications see:

Patient selection criteria for HBO2 treatment of specific indications, Parts 1,2 and 3. What follows in these sections is an abbreviated description of each illness with an overview of the usefulness of HBO2 as a primary or adjunct intervention in treating these conditions.

NOTE: While these are effectively ‘snapshots’ of each indication we strongly recommend a thorough reading of each chapter in the UHMS Indications book to appreciate the full view for HBO2 treatment of these conditions.

Taken from Moon RE, ed. Hyperbaric Oxygen Therapy Indications, 14 ed. North Palm Beach: Best Publishing, 2019: 1-13.

With material from ‘The benefits of hyperbaric oxygen therapy’ from Intermountain Healthcare – https://intermountainhealthcare.org/blogs/topics/live-well/2016/03/benefits-of-hyperbaric-oxygen-therapy/

Adapted by Renée Duncan, Communications, UHMS